Glucocorticoid attenuates a decrease of antithrombin III following major surgery

J Surg Res. 1998 Oct;79(2):158-63. doi: 10.1006/jsre.1998.5404.

Abstract

Background: Major surgery, such as esophagectomy, activates inflammatory responses and the coagulation system, and this activation is characterized by release of inflammatory cytokines and a decrease in antithrombin-III (AT-III), respectively. Preoperative glucocorticoid administration has been reported to suppress circulatory cytokine levels after major surgery.

Patients and methods: A total of 28 patients underwent esophagectomy for esophageal carcinoma; 14 of them were given 10 mg/kg of methylprednisolone intravenously upon induction of anesthesia and 14 served as controls. Circulating levels of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), polymorphonuclear (PMN) elastase, thrombin-antithrombin III complex (TAT), AT-III, and albumin were measured before and immediately after the operation and on postoperative days (PODs) 1, 3, 5, and 7.

Results: TNF-alpha, IL-6, and TAT levels significantly increased after esophagectomy in both groups. AT-III and albumin decreased to their minimum levels on POD 1 and POD 3, respectively. Methylprednisolone treatment effectively inhibited the increases in TNF-alpha and IL-6 and the decreases in AT-III and albumin, but did not inhibit the increases in PMN-elastase and TAT levels. There were significant correlations between AT-III, IL-6, and albumin levels.

Conclusions: These results suggest that methylprednisolone pretreatment attenuates the decrease in AT-III by reducing IL-6 production postoperatively.

MeSH terms

  • Aged
  • Antithrombin III / analysis*
  • Carcinoma / surgery
  • Cytokines / blood
  • Esophageal Neoplasms / surgery
  • Esophagectomy*
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Inflammation Mediators / blood
  • Leukocyte Elastase / blood
  • Male
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Osmolar Concentration
  • Postoperative Period
  • Time Factors

Substances

  • Cytokines
  • Glucocorticoids
  • Inflammation Mediators
  • Antithrombin III
  • Leukocyte Elastase
  • Methylprednisolone